Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.
Serogroup C meningococcal conjugate vaccines, first launched in the UK in 1999, have been used successfully in Australia, Canada and several other European countries. Combination conjugate vaccines, containing more than one meningococcal polysaccharide, have been developed to broaden protection agai...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
BMJ Publishing Group Ltd
2007
|
| Subjects: |